Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.85-0.33 (-4.60%)
At close: 1:00PM EST
6.85 0.00 (0.00%)
After hours: 01:01PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close7.18
Open7.09
Bid6.65 x 800
Ask8.03 x 1000
Day's Range6.66 - 7.10
52 Week Range6.20 - 13.98
Volume108,449
Avg. Volume218,328
Market Cap428.168M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.62
Earnings DateNov 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PSTX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Poseida Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 11/19/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    9 days agoArgus Research
View more
  • Zacks

    Wall Street Analysts Think Poseida Therapeutics, Inc. (PSTX) Could Surge 277%: Read This Before Placing a Bet

    The average of price targets set by Wall Street analysts indicates a potential upside of 276.7% in Poseida Therapeutics, Inc. (PSTX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

  • Benzinga

    4 Stocks Insiders Are Buying

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Poseida Therapeutics The

  • Benzinga

    Poseida Therapeutics Insider Sold Over $135K In Company Stock

    Eric Ostertag, Insider at Poseida Therapeutics (NASDAQ:PSTX), made a large insider sell on November 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Ostertag sold 18,924 shares of Poseida Therapeutics at a price of $7.09. The total transaction amounted to $134,171. Ostertag still owns a total of 3,519,151 shares of Poseida Therapeutics worth, $24,959,930. Poseida Therapeutics shares are trading up 1.03% at $7.

Advertisement
Advertisement